Houston vocabulary, from Texas law to the exam room. Sees no patients.
A medicine can have an ingredient name and a brand name. A research page may use another abbreviation. Write the full planned name down before comparing it with something read elsewhere. Ask whether the pages describe a matching ingredient, form and product.
These entries are about identifying what is being discussed. They do not choose a treatment or compare results. Use them to ask a prescriber what record supports the planned product and how it relates to the name that appeared in the original search.
B–G
Brand and generic names
A brand names a product; the generic name identifies its active ingredient.
In the September 26, 2026 record, semaglutide appeared in approved products named Ozempic and Wegovy, and tirzepatide appeared as Mounjaro and Zepbound.(a)
Keep the ingredient beside the brand in your notes. Ask which form is being discussed instead of using the brand as a shortcut. If a care page names only the ingredient, ask for the full product details before drawing a comparison with a branded medicine.
Generic product
A medicine that copies an earlier brand-name product and has its own FDA approval.
As of November 3, 2026, marketable approved generics of semaglutide and tirzepatide were absent, while liraglutide had approved generics, including weight-management products.(a)
FDA (the federal Food and Drug Administration) guidance did not accept describing a compounded drug as a generic version of an approved medicine.(b)
Ask what the speaker means when the word generic is used. Keep the product record with the answer. A phrase that sounds like a familiar pharmacy term still needs to match the drug being offered.
R
Research use only
A research label that needs to be read alongside the claims made for the substance.
In FDA warning letters checked September 26, 2026, sellers’ claims about use in people showed that they intended their products to be used as drugs. Calling them “research use only” did not change that conclusion.(c)
Those letters were allegations involving specific businesses, rather than court judgments.(c)
The practical question is what the full page is saying the product is for. Ask how any planned care product is identified and regulated. A research label does not supply a review of your health concern, a prescription or an approval record. Keep those questions in their own words.
Retatrutide
A substance described in research records, separate from approved treatment products.
Retatrutide still had no FDA approval in the November 3, 2026 record. FDA’s position checked that day was that federal law did not allow compounders to use retatrutide.(d)(a)
Ask what decision has actually been made about the medicine, such as whether FDA has approved it. A study, an announced plan and a product decision are different items to read. If a page says a medicine is awaiting something, ask what has actually been submitted and what has actually been decided. Do not let an expected future event replace the dated answer.
Keep names attached to records
Which product, form and ingredient does the care plan name?
Is the source a product record, a study or an announcement about a future plan?
Does the word generic refer to an approved product in this discussion?
What part of the answer is established, and what part is still uncertain?